Leadiant Biosciences, Inc. Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Vico Nel Lazio Italy (1957)
Status: No NME R&D (1957)

Organization Overview

First Clinical Trial
1999
NCT00010426
First Marketed Drug
1969
procarbazine (matulane)
First NDA Approval
1969
procarbazine (matulane)
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Leadiant Biosciences, Inc. | LEADIANT BIOSCI INC | Sigma Tau | SIGMA TAU | Sigma Tau HealthScience LLC | sigma-tau i.f.r. S.p.A. | Sigma-Tau Pharmaceuticals | Sigma-Tau Research, Inc. | Sigma Tau Research Switzerland SA | Sigma-Tau SpA